Stoke Therapeutics
STOK
STOK
126 hedge funds and large institutions have $422M invested in Stoke Therapeutics in 2025 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 45 increasing their positions, 30 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
11% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 27
34% less capital invested
Capital invested by funds: $640M → $422M (-$219M)
94% less call options, than puts
Call options by funds: $60K | Put options by funds: $973K
Holders
126
Holding in Top 10
3
Calls
$60K
Puts
$973K
Top Buyers
| 1 | +$15.8M | |
| 2 | +$7.85M | |
| 3 | +$3.48M | |
| 4 |
CC
Checkpoint Capital
San Francisco,
California
|
+$2.83M |
| 5 |
EAM
Erste Asset Management
Vienna,
Austria
|
+$2.67M |
Top Sellers
| 1 | -$2.6M | |
| 2 | -$2.16M | |
| 3 | -$1.33M | |
| 4 |
EAM
Exome Asset Management
New York
|
-$1.25M |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$1.15M |
